Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quantum Biopharma Ltd.

4.89
+0.38008.43%
Post-market: 5.700.8099+16.56%19:59 EDT
Volume:246.03K
Turnover:1.18M
Market Cap:9.42M
PE:-0.38
High:5.20
Open:4.80
Low:4.60
Close:4.51
Loading ...

Quantum BioPharma to be in court with Raza Bokhari on January 24

TIPRANKS
·
17 Jan

Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates

ACCESS Newswire
·
17 Jan

Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM

ACCESSWIRE
·
14 Jan

Quantum Biopharma Ltd. Approved to Dual List on Upstream

ACCESSWIRE
·
07 Jan

Quantum Biopharma Announces Closing of Second Tranche

ACCESSWIRE
·
21 Dec 2024

Quantum BioPharma invests $1M in BTC, cryptos for treasury diversification

CoinMarketCap
·
21 Dec 2024

Quantum Biopharma announces purchase of $1M of bitcoin and other cryptocurrencies

seekingalpha
·
20 Dec 2024

Quantum BioPharma Diversifies Treasury with the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency

GlobeNewswire
·
20 Dec 2024

Quantum Biopharma Announces Closing of First Tranche

ACCESSWIRE
·
14 Dec 2024

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

ACCESSWIRE
·
10 Dec 2024

Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million

ACCESSWIRE
·
05 Dec 2024

Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation

ACCESSWIRE
·
25 Nov 2024

Quantum BioPharma Ltd expected to post a loss of $3.90 a share - Earnings Preview

Reuters
·
09 Nov 2024

Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia

ACCESSWIRE
·
29 Oct 2024

QNTM Stock trading resumes

TIPRANKS
·
28 Oct 2024

QNTM Stock trading halted, volatility trading pause

TIPRANKS
·
28 Oct 2024